Identification of genes required for eye development by high-throughput screening of mouse knockouts by Moore, Bret, et al.
HAL Id: hal-02342264
https://hal.archives-ouvertes.fr/hal-02342264
Submitted on 31 Oct 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Identification of genes required for eye development by
high-throughput screening of mouse knockouts
Bret Moore, Brian Leonard, Lionel Sebbag, Sydney Edwards, Ann Cooper,
Denise Imai, Ewan Straiton, Luis Santos, Christopher Reilly, Stephen Griffey,
et al.
To cite this version:
Bret Moore, Brian Leonard, Lionel Sebbag, Sydney Edwards, Ann Cooper, et al.. Identification of
genes required for eye development by high-throughput screening of mouse knockouts. Communica-
tions Biology, Nature Publishing Group, 2018, 1 (1), ￿10.1038/s42003-018-0226-0￿. ￿hal-02342264￿
ARTICLE
Identiﬁcation of genes required for eye
development by high-throughput screening
of mouse knockouts
Bret A. Moore et al.#
Despite advances in next generation sequencing technologies, determining the genetic basis
of ocular disease remains a major challenge due to the limited access and prohibitive cost of
human forward genetics. Thus, less than 4,000 genes currently have available phenotype
information for any organ system. Here we report the ophthalmic ﬁndings from the Inter-
national Mouse Phenotyping Consortium, a large-scale functional genetic screen with the
goal of generating and phenotyping a null mutant for every mouse gene. Of 4364 genes
evaluated, 347 were identiﬁed to inﬂuence ocular phenotypes, 75% of which are entirely
novel in ocular pathology. This discovery greatly increases the current number of genes
known to contribute to ophthalmic disease, and it is likely that many of the genes will
subsequently prove to be important in human ocular development and disease.
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The prevalence and burden of ophthalmic disease within thehuman population, some with the potential for causingcomplete blindness, highlights the need to identify factors
that cause such conditions1–3. A wide variety of ocular diseases
are known to have an underlying genetic component. These
include single-gene disorders4 and multi-factorial ocular dis-
orders including age-related diseases with hereditary predisposi-
tions embedded in several risk alleles across the genome5.
However, the genetic contribution(s) for many ocular diseases
remains largely unknown or poorly understood4. Phenotype
information of any organ system is available for approximately
4000 genes at Online Mendelian Inheritance in Man (https://
www.omim.org/), illustrating the limited access and the prohi-
bitive cost of forward genetics in humans, despite advances in
next generation sequencing technologies. Altogether, the limita-
tions on genetic research in humans, the genetic variability
between individuals and among populations, the rarity of many
diseases, and the size of the mammalian genome together make
identiﬁcation of disease-causing alleles challenging.
Classical genetic techniques studying pedigrees of human
families affected by ocular disorders have identiﬁed numerous
genes associated with a wide array of eye diseases (e.g., see Retinal
Information Network - https://sph.uth.edu/retnet/). However,
gene discovery by pedigree analysis is limited. Studies exploring
genetic mechanisms in cellular biology have traditionally relied
upon single-gene deletions in animal models (largely mice) tar-
geted by individual laboratories, and by identiﬁcation of gene
mutations in mutagenesis screens6,7. Mice engineered to test
speciﬁc hypotheses may be made on variable or undeﬁned genetic
backgrounds, often without systematic or standardized multi-
system phenotyping that would reveal effects not anticipated in
the study design. Additionally, only ~50% of the estimated
~24,000 total protein-coding genes in the mouse currently have
experimentally derived functional information available, as
assessed by Gene Ontology annotation8. The current under-
standing of gene functions would be greatly enhanced by gene/
phenotype data from genetically invariant mouse strains (i.e.,
same background strain with manipulation of only the gene(s) in
question).
To address the fundamental problems in traditional methods
of studying genetic mechanisms in cellular biology and genetic
contributions to disease, the International Mouse Phenotyping
Consortium (IMPC) was established in 2011 as a network of
highly specialized academic centers with expertise in high-
throughput mouse mutagenesis and comprehensive phenotyp-
ing9,10. The IMPC consists of 18 laboratories in 12 countries
globally, and is supported by 5 national funding agencies
including the National Institute of Health (NIH). Figure 1 and
Table 1 highlight all relevant consortium partners who contribute
to data production. The goal of the IMPC is to create the ﬁrst
functional catalog of the mammalian genome by using the proven
methodology of phenotype screening of targeted gene mutagen-
esis in mice, which has been successful in identifying novel
pathologic loci across a wide range of organ systems11–15. The
large-scale production and characterization of the mouse genome
through single-gene deletion of all protein-coding genes using
multiple gene targeting strategies on a uniform C57BL/6N genetic
background is currently underway9,11,14,15.
To date, the IMPC has generated over 7000 genotype con-
ﬁrmed mutant strains, and has completed standardized pheno-
typing across 11 organ systems for 4364 of these genes. Access to
mouse resources and all phenotype data are publically available at
http://www.mousephenotype.org. Homozygous mice from all
viable strains and heterozygous mice from all subviable or lethal
strains have been subjected to ophthalmic examinations to
identify ocular phenotypes, which together with their associated
genotypes are presented here. Many novel genes previously
unknown to be involved with mammalian ophthalmic diseases
are presented, demonstrating successful identiﬁcation of mouse
mutants with early and delayed onset ocular phenotypes. This
report sheds new light on gene function, generates new models
for inherited eye diseases, and provides a roadmap for discovery
of relevant monogenic and complex human disorders. The
numerous novel pathologic loci revealed here serve as a powerful
resource for human ocular geneticists to scan whole genome
sequencing data in patients with presumed hereditary ocular
disease who do not have common mutations of known disease
genes. Finally, the murine loci identiﬁed in this manuscript, if
validated in human patient populations, would greatly increase
the number of known ocular disease genes found over the past
three decades since the discovery of rhodopsin gene mutations in
families with retinitis pigmentosa16,17.
Results
Primary phenotyping. The initial IMPC dataset search returned
4364 genes with completed phenotyping, each of which attained a
p-value threshold of 10−4 used to assign mutant phenotypes.
From the 4364 genes, a list of 347 genes with ocular phenotypes
was curated. Literature searches identiﬁed 42 genetic phenotypes
known to exist in vertebrates (Known Phenotype), 44 genes
described to cause an ocular phenotype differing from the phe-
notype described in the present study (Novel Phenotype), and
most interestingly, 261 genes (75% of genes with ocular pheno-
types) with no prior ocular implication (Novel Gene). The
number of genes within each of the three categories is shown in
Table 2. Anatomical abnormalities affecting several structures or
affecting the entire eye were categorized into groups: anterior
segment (any combination of adnexa, cornea, iris, or lens), pos-
terior segment (any combination of vitreous, retina, choroid,
posterior sclera, or optic nerve), and whole eye (any combination
across different ocular segments, e.g., retina and cornea, or eye
size and vitreous, etc.). Complete phenotype results, and complete
information on gene information and analysis are provided in
Supplementary Table 1. Selected ocular phenotypes are presented
below as exemplars.
Corneal phenotypes. A total of 25 knockout strains were found
to have only corneal opacities, 20 of which were completely novel
and unknown to be involved in the development of ocular phe-
notypes (Table 2). An additional 21 genes were identiﬁed with
multifocal ocular abnormalities that included corneal phenotypes,
and may represent candidates for anterior segment dysgenesis
syndromes, Peters’ anomaly, and other conditions of dysgenesis.
For example, Fam20a (Family with sequence similarity 20,
member A) knockout mice exhibited large paraxial corneal opa-
cities in a polygonal pattern, clearly visible on biomicroscopy
(Fig. 2a) and retro-illumination (Fig. 2b). The corneal opacities
corresponded histologically to superﬁcial stromal mineralization
(Fig. 2c). FAM20A deﬁciency has been linked to abnormal bio-
mineralization and is associated with enamel-renal syndrome in
humans18. Affected individuals suffer from amelogenesis imper-
fecta and nephrocalcinosis and/or nephrolithiasis18,19. Fam20a
knockout mice have been previously described, but no corneal
phenotype was reported20. NADSYN1 (NAD synthetase 1) is
implicated in vitamin D metabolism in humans. Nadsyn1-deﬁ-
cient mice develop chronic keratitis with neovascularization
(Fig. 2d), observable by histology (Fig. 2e). Mice deﬁcient in
Col6a2 (collagen type VI alpha 2) had very subtle corneal opa-
cities visible to the examiner, which was determined to be due to a
disorganized basket-weave appearance of the corneal stroma
(Fig. 2f) by electron microscopy, rather than the typical lamellar
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structure of this tissue (Fig. 2g) evident in wild type control
animals. The Col6a2 gene is known to be expressed in the central
corneal stroma of humans, but the phenotype of the cornea
deﬁcient in this protein has not been reported21.
Lens phenotypes. Cataracts are another important public health
concern1, and 79 strains bearing different single-gene deletions
were identiﬁed to only have lenticular abnormalities (113 genes
when considering multifocal ocular phenotypes) (Table 2). In
total, 63 of these genes with lens-only phenotypes were totally
novel, including Ndrg1 and Adamts18. Ndrg1 (N-myc down-
stream regulated gene 1) is implicated in pronephros develop-
ment and in cancer biology22,23. The Ndrg1 gene is a member of
the N-myc downregulated gene family and encodes a protein
involved in stress hormone responses as well as cell growth and
differentiation. In humans, it has described roles in Schwann cell
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Fig. 1 Schematic overview of IMPC data ﬂow from acquisition to web portal availability for public users. Data are collected from 12 phenotyping centers,
validated, and processed to produce curated data accessible on the project portal. Legacy data from EuroPhenome and Sanger MGP were directly
transferred to the Central Data Archive at EMBL-EBI for direct integration on the portal. https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/
gkt977. KMPC (Korea Mouse Phenotyping Center), MRC (Medical Research Council) Harwell Institute, HMGU (Helmholtz Zentrum Muenchen), MARC
(Model Animal Research Center), IMG (Institute of Molecular Genetics), WTSI (Wellcome Trust Sanger Institute), ICS (Institut Clinique de la Souris—
PHENOMIN-ICS), BCM (Baylor College of Medicine), JAX (The Jackson Laboratory), RBRC (RIKEN Bio-Resource Center), TCP (The Center for
Phenogenomics), UCD (University of California Davis), IMPReSS (International Mouse Phenotyping Resource of Standardized Screens https://www.
mousephenotype.org/impress)
Table 1 Ocular phenotyping protocols across all IMPC phenotyping mouse clinics
Primary screen Secondary screen
Center Mice Controls Slit lamp Indirect Other Additional modality
KMPC 7M, 7F B6N Yes Yes - -
MRC 7M, 7F B6N Yes Yes - Fundus Imaging, OCT
HMGU 7M, 7F B6N Yes Yes - OCT, LIB, VDT, Scheimpﬂug
MARC 7M, 7F B6N Yes Yes - -
IMG 7M, 7F B6N Yes Yes - -
WTSI 7M, 7F B6N Yes Yes - -
ICS 7M, 7F B6N Yes No OCT -
BCM 7M, 7F B6N No No OCT -
JAX 8M, 8F B6NJ Yes Yes - Fundus Imaging, ERG
RIKEN BRC 7M, 7F B6N Yes Yes - -
TCP 7M, 7F B6N Yes Yes Histology -
UCD 7M, 7F B6N Yes Yes Histology, tonometry Fundus Imaging, TEM, OCT, ERG
Slit-lamp examination was performed at all but one mouse clinic, and indirect fundus examination was performed at all but two mouse clinics, where routine OCT cross-sectional and funduscopic imaging
was performed. Secondary screening varied across structures and was based on desired testing and available equipment for further evaluation of a suspected or conﬁrmed phenotype See Fig. 1 legend for
deﬁnitions of Center abbreviations
ERG (electroretinography), TEM (transmission electron microscopy), OCT (optical coherence tomography), LIB (laser interference biometry), VDT (virtual drum test)
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trafﬁcking, microtubule dynamics and p53-mediated caspase
activation and apoptosis24–26. It is known that Ndrg1 is expressed
in the eye, but an ocular phenotype has not been identiﬁed27.
Ndrg1 knockout mice had bilateral defects in optical ﬁdelity
characterized by distinct concentric rings involving the anterior
and posterior lens cortex (Fig. 3a). The optical changes observed
clinically were not detectable by routine histopathologic evalua-
tion using light microscopy and were likely related to alterations
in refractive index. By contrast, Adamts18 (a disintegrin-like and
metallopeptidase with thrombospondin type 1 motif 18, repro-
lysin type) knockout mice had exceptionally large and refractile
crystalline opacities in the anterior vitreous, which were distinct
in appearance from C57BL/6N background lesions (Fig. 3b).
Upon histological examination, these opacities represented small
extrusions of lens material following posterior lens capsular
rupture (Fig. 3b). ADAMTS18 in human disease has been asso-
ciated with microcornea, ectopia lentis, and cone rod dystro-
phy28,29. Adamts18−/− mice represent only a partially
overlapping animal model for this human disorder given the
differences in phenotype expression30. Cdkn2a null mice pre-
sented histopathological manifestations of persistent hyperplastic
tunica vasculosa lentis/persistent hyperplastic primary vitreous
(PHTVL/PHPV), which was characterized by presence of a pig-
mented posterior retrolental ﬁbrovascular connective tissue
adherent to the posterior lens capsule often resulting in cataracts.
In the most severely affected case there was a posterior protrusion
(posterior lenticonus) where the lens was adhered to the retina at
the optic disc (Fig. 3c). The posterior lens capsule was segmen-
tally disrupted and there was a globular degeneration (Morgag-
nian globules) of the subcapsular lens protein (posterior
subcapsular cataract). The retinal segment was focally jumbled
(dysplastic) in this case. CDKN2A in human disease has been
linked to suppression of neoplastic growth, and knockout mice
have shown to develop early spontaneous tumors but no ocular
phenotypes31. However, another report showed that suppression
of Cdkn2a resulted in cataract development with failed regression
of the hyaloid vascular system similar to human PHPV, as found
in Cdkn2a knockout mice in the present study32.
Retinal phenotypes. Retinal diseases are the foremost cause of
blindness in the developed world, and studies to protect retinal
neurons from degeneration are a major area of active research33.
Ocular phenotyping in the IMPC pipeline identiﬁed 102 retina-
only phenotypes (139 phenotypes when considering genes leading
to multifocal ocular phenotypes), 17 of which are previously well
studied and published (Table 2). A total of 69 retinal phenotypes
involve genes that have no previously reported ocular phenotype,
and potentially represent novel human disease alleles. Arap1 (Arf
GAP with Rho GAP domain, ankyrin repeat, and PH domain 1)
is a large and complex soluble GTPase, which regulates mem-
brane biomechanics and lysosome maturation, but the extent of
its functions is not well understood34. This gene plays a role in
the recycling of the EGF receptor to the plasma membrane,
potentiating this signaling pathway35,36. Subsequent studies fol-
lowing primary phenotyping document progressive photo-
receptor degeneration in Arap1−/− mice, similar to retinitis
pigmentosa in humans37. Furthermore, Arap1 appears to be
expressed in Müller glial and RPE cells, not in photoreceptors
themselves, implicating a speciﬁc and novel dependence of pho-
toreceptors on Arap1 expression in neighboring cells38. Arap1−/−
animals developed a histologically normal retina by 2 weeks
postnatal age (Fig. 4a), similar to that of control mice (Fig. 4b). By
8 weeks postnatal, however, the Arap1−/− outer nuclear layer
degenerated substantially (Fig. 4c), unlike the age-matched con-
trol retinas (Fig. 4d). Our phenotyping efforts have also yielded
more subtle examples of retinal thinning, such as the Rnf10−/−
mouse (Fig. 4e), in which retinal thickness was lower compared to
control mice (Fig. 4f). Quantitation of retinal histology demon-
strates the global retinal thinning in these mutants, particularly in
the inner nuclear layer and inner plexiform layer (Fig. 4g): when
comparing to the control group examined in parallel, WT and
Rnf10−/− retinal thicknesses were respectively of 223.8 ± 3.9 µm
(n= 12 eyes) vs. 210.6 ± 4.5 µm (n= 14 eyes) for males (p=
4.10−8), of 222.4 ± 3.8 µm (n= 16 eyes) vs. 209.8 ± 4.8 µm (n=
13 eyes) for females (p= 2.10−8). The inner nuclear layer
thickness was 27.8 ± 2.1 µm vs. 24.7 ± 2.1 µm for WT and
Rnf10−/− males (p= 0.0013), 26.6 ± 2.3 µm vs. 25.0 ± 2.2 µm for
WT and Rnf10−/− females (p= 0.063). The inner plexiform
thickness was 56.6 ± 2.4 µm vs. 48.6 ± 2.9 µm for WT and
Rnf10−/− males (p= 8.10−8), 60.1 ± 2.9 µm vs. 46.6 ± 3.4 µm for
WT and Rnf10−/− females (p= 6.10−12). In a more global
comparison, 78.6% of the male (n= 14) and 84.6% of the female
(n= 13) (81.5% overall) Rnf10−/− retinas had a thickness below
the reference range. While only of 21.4% and 23.1% of the mutant
male and female eyes (22.2% overall) had an inner nuclear layer
thickness below the reference range, these percentages were 85.7%
and 100% (92.6% overall) when considering the inner plexiform
values. Rnf10, ring ﬁnger protein 10, may have a role in trans-
mitting NMDA receptor activity to the nucleus of hippocampal
neurons, and may have transcriptional regulation capability38,39.
Its role in the retina was previously unknown.
Mpdz (multiple PDZ domain protein) knockout mice exhibited
a mottled fundus (Fig. 5a, b) characterized by irregular bright
patches. The enhanced detection of retinal pigmented epithelium
(RPE) cells by fundus imaging (Fig. 5b) is typical of mouse
models of retinitis pigmentosa and Leber congenital amaurosis, in
which the outer retina has thinned or failed to develop40,41.
Scotopic and photopic electroretinography responses were absent
at 16 weeks of age (Fig. 5c), indicating a profound defect in rod
and cone photoreceptor function (Fig. 5d). MPDZ is a tight
junction protein and its silencing disrupts epithelial cell barrier
Table 2 Tabular depiction of genes found to have ocular
phenotypes arranged by the ocular tissue involved and the
novelty of the gene or phenotype
Ocular
tissue
Categorical
genes
(total)
Known
gene
(total)
Novel
phenotype
(total)
Novel
gene
(total)
Adnexa 8 (20) 0 (3) 0 (1) 8 (16)
Cornea 25 (46) 1 (6) 4 (4) 20 (36)
Iris 5 (19) 0 (6) 0 (1) 5 (12)
Lens 79 (113) 6 (13) 10 (13) 63 (87)
Vitreous 22 (40) 2 (4) 3 (4) 17 (32)
Retina 102 (139) 17 (24) 16 (20) 69 (95)
Optic nerve 4 (8) 0 (2) 0 (0) 4 (6)
Eye size 11 (18) 1 (1) 3 (4) 7 (13)
Neuro 13 (20) 0 (2) 1 (3) 12 (15)
AS Combo 24 5 3 16
PS Combo 6 1 1 4
Whole Eye 48 9 3 36
Total 347 42 44 261
A total of 347 different genes were identiﬁed. Of these, 42 genes had phenotypes that have
been previously described, 44 genes had phenotypes that differed from previously described
ocular phenotypes, and 261 genes previously not known to cause ocular disease were found to
have ocular phenotypes. AS Combo represents combination of multiple anterior segment
structures (i.e., adnexa, cornea, iris, or lens), PS Combo represents combination of multiple
posterior segment structures (i.e., vitreous, retina, or optic nerve), and Whole Eye represents
phenotype spanning multiple ocular segments (e.g., anterior and posterior). Neuro represents
an abnormality of the pupillary light reﬂex. In parentheses, the total number of genes affecting a
given ocular tissue is shown including genes affecting multiple ocular tissues
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function in vitro42,43. The protein has been localized to the mouse
retinal external limiting membrane (ELM) and RPE, thus
potentially compromising ELM or RPE barrier function in the
knockout strain44,45. Mpdz variants are associated with hydro-
cephalus, foveal dysplasia, and inner retinal thinning in humans.
Detailed analysis of mouse ocular phenotypes are consistent with
human ocular phenotpyes, and in an independent mouse
knockout model, but ocular phenotypes have not been reported
thus far43,46–48.
Gene enrichment analysis. Using a gene ontology enrichment
analysis, Wnt signaling pathways were shown to be considered
important signaling pathways for all 347 genes including known
phenotypes (Supplementary Figs. 1–4 and Tables 2–4). In a
subset analysis of the 261 novel genes, oxidation-reduction pro-
cesses (28 genes) and histone H3-K36 dimethylation pathways (3
genes) are the top-ranked functional annotations (p-value, 5.16E-
0.5 and 4.76E-04, respectively). Cataract and lens morphology
phenotypes were observed in mice with the majority of genes
associated with oxidation-reduction process (n= 15/28, 54%).
Oxidative stress is an important pathogenic mechanism in
numerous eye diseases including age-related macular degenera-
tion, glaucoma, or cataract49,50.
Discussion
Large-scale ocular screens as part of the IMPC phenotyping
pipeline of mutant mice have revealed a large number of mutants
with ocular phenotypes. With deletion of 4364 genes being ana-
lyzed at the time of this writing we report 347 ocular phenotypes,
261 of which are novel and may serve as a powerful tool in future
genetic research of human ocular disease. If validated in humans,
the genes described here would greatly increase the number of
known ocular disease genes. Genes not described here that would
be suspected to have ocular phenotypes based on known human
counterparts may have been lethal knockouts or may have not yet
been phenotyped. Information on all tested genes can be found at
www.mousephenotype.org51. A total of 86 knockout strains had
genes deleted that are previously known to cause ocular pheno-
types (44 novel phenotypes, and 42 known phenotypes), 25 of
which knockout strains have not yet been created. In many cases,
knockout mice for these genes have been previously reported, and
in other cases the deleted gene has a known disease-causing
mutation in human pedigrees, or in other vertebrate genetic
models such as zebraﬁsh. However, for these 86 known disease-
causing genes, the mice phenotyped in this study may represent
novel mouse models of human disease states. A total of 205 of
these novel models exhibit isolated ocular ﬁndings, while 56
others recapitulate syndromic patterns affecting ocular tissues as
well as other organ systems, as previously reported in mouse
mutational studies52. These models can be used for various forms
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Adamts18 –/– Cdkn2a –/–
Fig. 3 Lenticular abnormalities in Ndrg1, Adamts18, and Cdkn2a knockout mice. a Retro-illumination highlights the well-deﬁned concentric annular anterior
and posterior cortical optical discontinuities in Ndgr1 knockout mice (arrow, scale bar= 500 µm). bMice deﬁcient in Adamts18 knockout mice had clinically
evident vitreous crystalline deposits, which represented extruded lens material (arrow, scale bar= 100 µm). c Cdkn2a knockout mice had ocular lesions
consistent with persistent tunica vasculosa lentis, with most severe cases having posterior lenticonus where the lens was adhered to the retina at the optic
disc. The posterior lens capsule was segmentally disrupted and there was posterior subcapsular cataract. Additionally, the retinal segment was focally
dysplastic. Scale bar= 500 µm
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Fig. 2 Corneal abnormalities in Fam20a, Col6a2, and Nadsyn1 knockout mice.
Biomicroscopy (a) of Fam20a knockout mice revealed polygonal opacities
with indistinct edges and interweaving clear spaces in the corneal stroma
(arrow), which were also apparent (arrow) on retro-illumination (b), scale
bars= 500 µm. Histology (c) shows superﬁcial stromal mineralization
(arrow, scale bar= 50 µm). Corneal vascularization (arrow) and chronic
superﬁcial keratitis (arrowheads) were observed in Nadsyn1 knockout mice
(d, scale bar= 500 µm), and red blood cells (arrow) are shown in the
lumen of neovascular vessels on histology (e, scale bar= 20 µm). Mice
lacking Col6a2 had subtle corneal stromal opacities seen on slit-lamp
examination, which electron microscopy revealed to be a basket weaving
appearance (arrowheads) of the corneal stroma (f) that was not seen in
wild type (WT) controls (g), scale bars= 5 µm
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of translational research, including therapeutic testing of potential
medications, gene therapy, or stem cell-based studies.
All knockout mice in this study were made on the C57BL/6N
strain, which is homozygous for the Crb1rd8 mutation that is
associated with retinal dysplasia53,54, and depending on the strain
background, slow retinal degeneration55,56. These mice also
exhibit other ocular abnormalities associated with the strain
genetic background, occurring at different frequencies, including
corneal deposits, altered anterior lens capsular translucency,
punctate nuclear cataracts, and vitreous crystalline and/or pig-
mentary opacities57. It should be acknowledged that a very small
portion of the genes presented here may be disease-modifying
genes, and may cause only a mild or no detectable ocular phe-
notype, and/or a delay in phenotype appearance, when knocked
out in the context of other strains not carrying the Crb1rd8 alleles.
Additionally, because mice were only examined up to 16 weeks of
age, late-onset phenotypes may have been overlooked. However,
it is important to note that the intent of the IMPC project is to do
a ﬁrst pass screen to generate hypotheses and assign a functional
annotation to the vast majority of genes for which there is little to
no knowledge of biological function or pathologic role. Speciﬁc
genes can then be explored further, including through elaboration
of functions not assessed in the IMPC pipeline, where additional
important pathophysiologic information about the disease
mechanism underlying the observed pathology may be obtained.
Select knockout mouse strains have been chosen for advanced
analysis in separate studies by some of the authors of this
manuscript, and in some instances, the knockouts have been bred
away from the Crb1rd8 mutation40.
Ophthalmic diseases with a genetic basis can be part of a multi-
system syndrome, or they can be caused by either single- or
multi-gene disorders limited to the eye. In general, multi-system
hereditary conditions that affect the eye are relatively uncommon
and make up only a small segment of ocular disease. The IMPC
project has the potential to identify genetic disorders that affect
more than just the eye. Through comprehensive phenotyping,
associations between ocular and systemic abnormalities that
might not have been detected thus far in the human population
can be discovered. For example, observing that a given knockout
mouse with kidney abnormalities has a concomitant retinal
degeneration may motivate genetic researchers to evaluate this
gene as a potential oculo-renal syndrome or syndromic cillio-
pathies, of which causation by several single-gene mutations are
known58–60. Knockouts of several genes described in this study
with previously unreported ocular phenotypes were found to have
coexisting kidney disease: Aqp6, Dnase1l2, Efna5, Fgf7, and Galk2.
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Fig. 4 Retinal thinning in Arap1 and Rnf10 knockout mice. Arap1−/− mice had normal appearing retinal tissue at 2 weeks postnatal age (a) in comparison to
wild type (WT) littermate control animals (b). The outer nuclear layer (asterisks in a, c) progressively degenerated (c) by 8 weeks postnatal in Arap1−/−
mice, when compared with littermate control eyes (d). Scale bars= 50 µm. Optical coherence tomography of Rnf10−/− mice (e) shows statistically
signiﬁcant retinal thinning by 16 weeks postnatal age when compared to control retinal images (f). Scale bar= 100 µm. Box plots of male and female
Rnf10−/− mice document retinal thinning (g) in comparison to normal age-matched controls, particularly affecting the inner plexiform layer (IPL) (h), and
the inner nuclear layer. Error bars represent the standard deviation (SD) for the knockout measurements. Data points outside of the mean+ /- SD range
are represented by black circles. The two dotted red lines delimit the reference range, deﬁned as two SD away from the mean for controls, represented by
the solid red line
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Comprehensive phenotyping of all organ systems as performed
by the IMPC may provide many other multi-systemic disease
associations and useful insights for understanding and treating
human disease, including but not limited to identifying pathways
involed in disease progression, identiﬁcation of biomarker can-
didates for disease analysis, and surrogate measures for ther-
apeutic testing.
The majority of ocular diseases show strong Mendelian
inheritance patterns suggestive of single-gene causation. How-
ever, multi-gene disorders, resulting from several single-
nucleotide polymorphisms in various genes that ultimately con-
tribute to the observed phenotype, exist and are often associated
with aging as commonly seen in age-related macular degenera-
tion, diabetic ocular disease, and some forms of cataract, glau-
coma, and corneal disease1,61,62. In recent years, genome-wide
association studies have revealed surprising and important
genetic risk alleles for ocular diseases, and the discovery of single-
gene mutations/deletions causing ocular disease, as provided in
this study, may be relevant in a host of multi-factorial diseases
afﬂicting the aging population61–64. More immediately impactful
in clinical ophthalmology are the single-gene disorders with
Mendelian patterns of inheritance as reported in the present
study. Not only can the novel genes reported here be used to
develop allele-speciﬁc models for translational research of human
diseases, which can form the foundation for future human trials,
they may rapidly impact diagnostics in clinical ophthamology.
For example, when a patient presents to an ophthalmologist with
ocular disease that is suspected to be inﬂuenced by heritability,
blood can be tested relatively inexpensively and efﬁciently
screened using genetic arrays to test for common mutations of
known genes65. If no commonly known genetic mutations are
identiﬁed on the initial genetic array, the decision can be made to
invest in whole exome or whole genome sequencing. Once the
expanded genomic data are available for the patient, the coding
sequence for known disease genes can be analyzed for uncommon
mutations not on the array, or for novel unpublished mutations
in known genes.
This strategy has been successful in identifying the disease-
causing mutation in 15–35% of patients with hereditary eye
disease66. The clinician-geneticist is then faced with the bioin-
formatics problem of isolating the single mutated gene within the
patient’s entire genome sequencing data. Interrogation of the
genome using next generation sequencing can detect 40–55% of
mutations67,68. Finding the remaining half of the mutations is an
incredibly challenging and time consuming problem when the
geneticist has run out of candidate genes to examine, and is
forced to examine the remainder of coding and non-coding
sequences in an unbiased fashion. This is where identifying novel
disease-causing mutations through animal screens represents a
powerful tool. The 256 completely novel genes and 48 genes
reported here with novel phenotypes (302 total genes) approx-
imate the known number of eye disease-causing loci in mammals,
and may help direct human geneticists to candidate genes that
will likely be relevant in human ocular disease and blindness69.
The identiﬁcation of candidate genes tremendously increases
the efﬁciency of such a bioinformatics challenge by guiding the
queries to examine an expanded pool of potential candidate
genes, and by decreasing the number of cases that must be
arduously performed in an unbiased methodology. We anticipate
that the list of genes identiﬁed here will guide human geneticists
to the identiﬁcation of relevant disease genes in humans70. Fur-
thermore, the mice produced in the pipeline are available from
public resources, such as the NIH-supported Mutant Mouse
Resource and Research Centers (MMRRC) or the European
Mouse Mutant Archive (EMMA). These animals are immediately
available and hold the potential for being validated as relevant
models of human ocular diseases. Once validated, they can be
used to accelerate identiﬁcation and development of lead ther-
apeutic compounds employing small molecules, biologics, gene
therapies, and cell-based treatments. Finally, many of the genes
reported here have not previously been recognized to play a role
in the visual system, establishing an expanded menu of potential
therapeutic targets once signaling pathways are established.
Methods
Animals. All IMPC centers maintain strict ethical review licensing and accrediting
bodies that are reﬂective of their national legislation (Institutional Animal Care and
Usage Committees, Regierung von Oberbayern, Com’Eth, Animal Welfare and
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Fig. 5 Ocular phenotypes of homozygous C57BL/6NJ-Mpdzem1J/J (Mpdz−/−) and control C57BL/6NJ (B6NJ) mice. Bright-ﬁeld fundus images at 14 weeks
of age (a). Detail of a showing enhanced detection of RPE cells (b) in mutant mice. Scale bar in a= 250 µm. ERG traces (c) from the left and right eyes of
B6NJ (blue) and Mpdz−/− (red) mice (n= 4 both strains) at 16 weeks of age. The mean of all traces is shown in black. Scale bars, 100µV vertical, 50 ms
horizontal. Summary of ERG response amplitudes (d) for data in b. Bars show mean ± SD; p-values from t-tests are indicated
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Ethical Review Bodies, RIKEN Tsukuba Animal Experiments Committee, and
Animal Care Committee). Phenotyping procedures consortium-wide were assessed
routinely for animal welfare and reﬁned where applicable to minimize suffering.
Electroretinograms were performed in complicance with the Association for
Research in Vision and Ophthalmology statement for the Use of Animals in
Ophthalmic and Vision Research.
All mice are IMPC generated knockout lines using principally the International
Knockout Mouse Consortium tm1.1 and tm1b null alleles, but also including a
small number of CRISPR/Cas9-induced mutations that employ an exon deletion
stragegy9. Homozygous viable mutants enter an extensive adult phenotyping
pipeline that includes a range of phenotyping tests that evaluate a diverse range of
physiological systems, including the visual sensory system.
Cohorts of a minimum of seven male and seven female adult mice, homozygous
for a disrupted allele on a C57BL/6N genetic background, along with two male and
two female wild-type littermates per genetic knockout, were produced.
Approximately 24% of the strains were homozygous embryonic lethal or subviable,
necessitating adult phenotyping of adult heterozygous mice. Morphological
imaging and other analyses of embryos harvested at various stages of development
was carried out in order to determine the time and likely cause of death12.
Phenotyping began at 4 weeks of age, followed by weekly body weights, and more
in-depth phenotyping from 9 through 16 weeks of age. Mice were euthanized at
16 weeks and tissues and blood were collected for anatomic and clinical pathology.
Testing and data collection were performed using standardized operating protocols
shared among IMPC centers, with sufﬁcient ﬂexibility for each phenotyping center
to explore additional secondary phenotype tests while maintaining rigorous
principles of scientiﬁc consistency and reproducibility71. At all sites, phenotype
assessment and interpretation were made by specialized personnel with expertise in
a variety of ﬁelds, including pathologists, veterinarians, radiologists,
ophthalmologists, cardiologists, and scientiﬁc experts in neurobehavior,
metabolism, cardiovascular physiology, musculoskeletal anatomy, and sensory
nervous systems.
Available data and annotated images are viewable and accessible for download
online at www.mousephenotype.org51. The IMPC uses a rigorous and structured
pipeline for collecting data (Fig. 1). Local phenotyping centers collect data in their
Laboratory Information Management Systems based on the IMPReSS protocols
(International Mouse Phenotyping Resource of Standardized Screens https://www.
mousephenotype.org/impress) where the parameters and metadata types are
strictly deﬁned. The centers then collate their experimental data and publish XML
(Extensible Markup Language) documents as deﬁned by the IMPReSS protocols
and the IMPC designed Schema Deﬁnition Language. The documents are stored on
a local Secure File Transport Protocol server until the Data Coordination Center at
MRC Harwell can download them for processing, validation, and quality control
(QC). The Data Coordination Center then checks the data for completeness and
QC, and also compares the data against the production information in the
International Micro-Injection Tracking System. Some preliminary data analyses are
employed to detect subtle QC issues that may indicate process or equipment
problems. Data that passes the ﬁnal QC are sent to the Core Data Archive where
statistical analysis is performed by the PhenStat program to identify statistically
validated phenotypes72. At that point, the curated data are made available to the
public at the IMPC (http://www.mousephenotype.org/).
Primary phenotyping. Complete ophthalmic examinations were performed on
both eyes of each mouse at 15–16 weeks of age. A standardized operating protocol
for evaluation of ocular and adnexal structures was followed by all study sites
(https://www.mousephenotype.org/impress/protocol/267/7). Biannual meetings of
consortium participants were held to troubleshoot the ocular phenotyping protocol
in order to maintain high-quality data management. Examinations were carried out
by highly trained and experienced technical support staff trained to identify and
differentiate background lesions common in the C57BL/6N strain57. Examiners
were overseen by lead site scientists who subsequently reviewed all phenotypes.
Speciﬁc phenotyping modalities utilized at each site are summarized in Table 1.
Examiners were unaware of knockout and wild-type status and of the speciﬁc
genetic deletion during examinations. Each cohort of knockout mice was examined
with genetic wild-type controls of both sexes mixed into the cohort. If ocular
phenotypes were discovered in a cohort of mice, they were considered to be due to
the knockout genotype only if they were identiﬁed in the knockouts and not in the
controls. This process reduced the chance for false positives being identiﬁed as
examiners were masked to a mouse’s genotype. Pupillary light reﬂexes were
evaluated, the eyelids, third eyelid, conjunctiva, sclera, cornea, iris, and anterior
chamber were examined using broad beam illumination at the highest intensity
setting (Kowa SL-15, Kowa, Tokyo, Japan, or equivalent) with magniﬁcation set at
16 × . The irides of all mice were then pharmacologically dilated with a solution of
1:7 10% phenylephrine HCl (Akorn Inc., Lake Forest, IL, USA, or equivalent): 1%
tropicamide (Bausch & Lomb Inc., Tampa, FL, USA, or equivalent). A 0.1 mm slit
beam at the highest intensity setting to evaluate the anterior segment (cornea,
anterior chamber, and lens), followed by posterior segment evaluation including
the vitreous chamber. Fundus examinations were performed via indirect
ophthalmoscopy using a 60 Diopter double aspheric handheld lens (Volk Optical
Inc, Mentor, OH, USA or equivalent) and a portable indirect headset (Keeler
AllPupil II LED Vantage Plus Wireless Headset, Keeler Instruments Inc., Broomall,
PA, USA, or equivalent).
Acquired incidental (i.e., trauma) ﬁndings were identiﬁed based on lesion
characteristics and lack of repeatability in a given cohort. Background lesions were
identiﬁed based on expected changes associated with the strain-speciﬁc C57BL/6N
and retinal degeneration 8 (rd8) mutations in Crb153. Findings in both categories
were excluded from reported results. Background ﬁndings known for the C57BL/
6N line include corneal stromal opacities, altered anterior lens capsule
translucency, pulverulent nuclear cataracts, vitreous pigment and crystalline
opacities, retinal dysplasia, and microphthalmia57. Except in knockout strains that
greatly increased the frequency of these speciﬁc lesions, background lesions
occurred at approximately equal frequencies among knockout and wild-type lines
as previously described57.
Histology. Physiologic data were supported by histopathology, which continues to
be the deﬁnitive assay in medicine for making most diagnoses73,74. For pipeline
histopathologic evaluation, eyes were either enucleated or ﬁxed in situ. Tissues were
immersion ﬁxed in 10% neutral-buffered formalin. If ﬁxed in situ, formalin-ﬁxed
heads were decalciﬁed in 15% picric acid for at least 24 h or until sufﬁcient dec-
alciﬁcation was achieved. Parasagittal sections of eyes or coronal sections through
the head including eyes were processed routinely for histopathology, embedded in
parafﬁn, sectioned at 4–5 µm, and stained with hematoxylin and eosin.
For targeted anterior segment histology, eyes were enucleated, ﬁxed in 10%
neutral-buffered formalin, washed in three changes of 100% ethanol for 15 min
each, two 15 min changes of 100% xylene, and three 45 min changes of 60C
parafﬁn. Sections 4 µm thick were cut using a Leica microtome and de-parafﬁnized
prior to staining. For targeted evaluation of the retina, eyes were enucleated and
frozen in Optical Cutting Temperature Compound (Fisher HealthCare, Houston,
TX, USA) using liquid nitrogen. Cryosections were prepared at 10 µm thickness on
Superfrost Plus slides (Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA).
Sections were treated with cold acetone, hematoxylin, 0.5% HCl in 70% ethanol,
eosin, 95% and 100% ethanol, and Histo-Clear (National Diagnostics, Atlanta,
GA). Slides were coverslipped with Vectamount and imaged. The histologic
ﬁndings were evaluated by an anatomic pathologist (in all speciﬁc examples
presented in the results, by a board-certiﬁed veterinary anatomic pathologist: D.M.
I., C.R.).
Electron microscopy. Selected cases were examined by transmission electron
microscopy (TEM). Eyes were immediately placed in 4% glutaraldehyde and 2%
PFA in PBS for 2+ h at 4 °C, thoroughly washed with PBS, and cut into squares.
Small pieces of tissue were ﬁxed in 1% osmium tetroxide in 0.1 M phosphate buffer
(pH 7.3) for 1 h. After buffer rinses, the pieces were dehydrated in a graded series of
ethanol, incubated in propylene oxide, then inﬁltrated and embedded with epoxy
resin (Poly/Bed 812; Polysciences Inc.). Initial sections of tissue were obtained by
bright-ﬁeld microscopy, and thin sections were cut from selected areas, stained
with uranyl acetate and lead citrate, and examined with a Philips CM120 trans-
mission electron microscope.
Ocular imaging. All mice diagnosed with ocular lesions suspected to be a
genetic phenotype were ﬂagged for further examination via advanced imaging
techniques. Mice were anesthetized with an intraperitoneal injection of a
ketamine/midazolam (50–75/1–2 mg/kg) cocktail. Eyes were dilated with tro-
picamide 1% and phenylephrine 2.5% drops, and lubricated with methylcel-
lulose containing artiﬁcial tears. Slit-lamp anterior segment photographs were
taken with a BQ900 slit lamp (Haag-Streit, Switzerland). Fundus images were
obtained with the Micron III or IV (Phoenix Research Laboratories, Plea-
santon, CA, USA). Video acquisitions of 100 frames were registered, averaged,
and sharpened digitally as described75. Spectral domain OCT images were
captured with the Bioptigen Envisu R2200 (Leica Microsystems, Wetzlar,
Germany). Retinal and layer thickness are indicated as mean ± standard
deviation (SD) and were comparing using a Student t-test to the control group
examined in parallel. For a given type of measurement, the reference range is
deﬁned as the mean ± 2 SD of all control measurements.
Electroretinography. Electroretinography (ERG) studies were conducted at
institutions where available (see Table 1), on mice at 16 weeks of age for each
knockout line (two males, two females) and, on a weekly basis, C57BL6/NJ (JAX
stock #005304) control mice (two males, two females). An Espion2 Electro-
retinography System (Diagnosys, LLC, Lowell, MA) was used to assess ﬂash-
induced voltage changes in both eyes of animals. Mice were either dark-adapted for
2 h prior to exam and stimulated by ﬁve ﬂashes at an illuminance of 0.25 cd·s/m2
and a frequency of 0.1 Hz (scotopic condition), or light-adapted for 8 min with a
110 cd/m2 background illumination and additionally stimulated on this back-
ground with 20 ﬂashes at an illuminance of 10 cd·s/m2 and a frequency of 1 Hz
(photopic condition). The color temperature of all stimuli and background illu-
mination was 6500 K. Flashes under each condition were averaged and amplitudes
determined using the Espion2 software. ERG response amplitudes from the left and
right eye of each mouse were averaged, and the mean values from the mutant and
control cohorts were analyzed statistically in Prism (GraphPad Software, Inc., La
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Jolla, CA) using Student’s t-test. ERG trace data from each eye was exported from
the Espion2 software and graphed in Prism.
Gene analysis. The initial list of eye phenotypes was developed by searching the
IMPC web portal for non-speciﬁc eye phenotypes in an effort to obtain all
relevant knockouts with ocular phenotypes (http://www.mousephenotype.org/
data/search/mp?kw=eye). Phenotypes only recognized at gross pathology or
histopathology stages were excluded, as were embryologic eye phenotypes, since
IMPC statistical thresholds were not applied to phenotypes discovered by these
methods. The initial list was analyzed to identify unique genes with ocular
phenotypes. The list of knockouts was then categorized based on the region of
the eye in which the phenotype was detected. Genes associated with an ocular
phenotype were then reviewed by searching www.pubmed.gov and www.google.
com/scholar for each unique gene and the search term eye, the affected anato-
mical structure (e.g., cornea), and the term knockout to determine if a genetic
knockout has been made. If the search yielded an example of at least one ver-
tebrate species with a published ocular phenotype that was similar to the phe-
notype found in the present study, the genetic phenotype was categorized as a
Known Phenotype. If the search yielded evidence of an ocular phenotype for a
given genetic knockout, but the phenotype was of a different ocular tissue (e.g.,
cornea vs. retina), then the genetic phenotype was called Novel Phenotype.
Knockouts in the Novel Phenotype category are still considered novel mouse
models of ocular disease. If the search yielded no publications on ocular
phenotypes of a given gene, the genetic phenotype was categorized as Novel
Gene.
Gene enrichment analysis. We used the DAVID functional annotation tool
(version 6.8) to examine whether particular gene ontology (GO) terms of biological
processes are enriched in a list of genes associated with the eye phenotype (com-
bined, known, or novel)76. All GO terms of GOTERM_BP_FAT with modiﬁed
Fisher exact p-values <0.05 were plotted with ReviGO with default options77. We
manually classiﬁed GO terms into representative GO groups in the ReviGo
interactive graph. To reconstruct a network model of novel genes associated with
the eye phenotype, we collected their experimentally validated protein–protein
interactions from ﬁve protein–protein interactome databases: BioGRID (version
3.4.147)78, HitPredict (version 4)79, IntAct (version 2017-03-02)80, DIP (version
2017-02-05), and MINT (version)81. We also collected predicted protein–protein
interactions for the novel genes from STRING (version 10.5)82. The network model
was built with the novel genes and their combined protein–protein interactions
using Cytoscape (version 3.5.1)83. We then overlapped the eye location of the novel
genes and their membership of the representative GO groups in the constructed
network model.
Disclaimer. The content is solely the responsibility of the authors and does not
necessarily represent the ofﬁcial views of the National Institutes of Health
Data availability
Data are available from the IMPC at www.mousephenotype.org. Post-QC data
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download (Phenoview).
Received: 24 May 2018 Accepted: 6 November 2018
References
1. Eye Diseases Prevalence Research Group. Causes and prevalence of visual
impairment among adults in the United States. Arch. Ophthal. 122, 477–485
(2004).
2. Ko, F. et al. Prevalence of nonrefractive visual impairment in US adults and
associated risk factors, 1999–2002 and 2005–2008. JAMA 308, 2361–2368
(2012).
3. Bourne, R., Price, H. & Stevens, G. Global burden of visual impairment and
blindness. Arch. Ophthalmol. 130, 645–647 (2012).
4. Stone, E. M. et al. Clinically focused molecular investigation of 1000
consecutive families with inherited retinal disease. Ophthalmol 124,
1314–1331 (2017).
5. Warwick, A. & Lotery, A. Genetics and genetic testing for age-related macular
degeneration. Eye (Lond). 32, 849–857 (2017).
6. Hrabe de Angelis, M. et al. Analysis of mammalian gene function through
broad-based phenotypic screens across a consortium of mouse clinics. Nat.
Genet. 47, 969–978 (2015).
7. White, J. K. et al. Genome-wide generation and systematic phenotyping of
knockout mice reveals new roles for many genes. Cell 154, 452–464
(2013).
8. The Gene Ontology Consortium. Expansion of the Gene Ontology
knowledgebase and resources. Nucl. Acids Res. 45, D331–D338 (2017).
9. Skarnes, W. C. et al. A conditional knockout resource for the genome-wide
study of mouse gene function. Nature 474, 337–342 (2011).
10. Brown, S. D. & Moore, M. W. Towards an encyclopedia of mammalian gene
function: the International Mouse Phenotyping Consortium. Dis. Model Mech.
5, 289–292 (2012).
11. Brown, S. D. & Moore, M. W. The International Mouse Phenotyping
Consortium: past and future perspectives on mouse phenotyping. Mamm.
Genome 23, 632–640 (2012).
12. Dickinson, M. E. et al. High-throughput discovery of novel developmental
phenotypes. Nature 537, 508–514 (2016).
13. Morgan, H., Simon, M. & Mallon, A. M. Accessing and mining data from
large-scale mouse phenotyping projects. Int. Rev. Neurobiol. 104, 47–70
(2012).
14. Bowl, M. R. et al. A large scale hearing loss screen reveals an extensive
unexplored genetic landscape for auditory dysfunction. Nat. Commun. 8, 886
(2017).
15. Rozman, J. et al. Identiﬁcation of genetic elements in metabolism by high-
throughput mouse phenotyping. Nat. Commun. 9, 288 (2018).
16. Dryja, T. P. et al. A point mutation of the rhodopsin gene in one form of
retinitis pigmentosa. Nature 343, 364–366 (1990).
17. Sung, C. H. et al. Rhodopsin mutations in autosomal dominant retinitis
pigmentosa. Proc. Natl Acad. Sci. USA 88, 6481–6485 (1991).
18. Wang, S. K. et al. FAM20A mutations can cause enamel-renal syndrome
(ERS). J. Dent. Res. 93, 42–48 (2014).
19. Kantaputra, P. N. et al. Enamel-Renal-Gingival syndrome, hypodontia, and a
novel FAM20A mutation. Am. J. Med. Genet. A. 164A, 2124–2128 (2014).
20. Vogel, P. et al. Amelogenesis imperfecta and other biomineralization defects
in Fam20a and Fam20c null mice. Vet. Pathol. 49, 998–1017 (2012).
21. Liu, Y. et al. Gene expression proﬁle of extracellular matrix and adhesion
molecules in the human normal corneal stroma. Curr. Eye Res. 21, 1–8 (2016).
22. Kyuno, J., Fukui, A., Michiue, T. & Asashima, M. Identiﬁcation and
characterization of Xenopus NDRG1. Biochem. Biophys. Res. Commun. 309,
52–57 (2003).
23. Cen, G., Zhang, K., Cao, J. & Qiu, Z. Downregulation of the N-myc
downstream regulated gene 1 is related to enhanced proliferation, invasion
and migration of pancreatic cancer. Oncol. Rep. 37, 1189–1195 (2017).
24. Hunter, M. et al. NDRG1 interacts with APO A-I and A-II and is a functional
candidate for the HDL-C QTL on 8q24. Biochem. Biophys. Res. Commun. 332,
982–992 (2005).
25. Shi, X. H., Larkin, J. C., Chen, B. & Sadovsky, Y. The expression and
localization of N-myc downstream-regulated gene 1 in human trophoblasts.
PLoS ONE 8, e75473 (2013).
26. Stein, S. et al. NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem.
279, 48930–48940 (2004).
27. Takita, S., Wada, Y. & Kawamura, S. Effects of NDRG1 family proteins on
photoreceptor outer segment morphology in zebraﬁsh. Sci. Rep. 6, 36590
(2016).
28. Aldahmesh, M. A. et al. The syndrome of microcornea, myopic chorioretinal
atrophy, and telecanthus (MMCAT) is caused by mutations in ADAMTS18.
Hum. Mutat. 34, 1195–1199 (2013).
29. Chandra, A. et al. Expansion of ocular phenotypic features associated with
mutations in ADAMTS18. J. Am. Med. Assoc. Ophthalmol. 132, 996–1001
(2014).
30. Ataca, D. et al. Adamts18 deletion results in distinct developmental defects
and provides a model for congenital disorders of lens, lung, and female
reproductive tract development. Biol. Open. 5, 1585–1594 (2016).
31. Serrano, M., et al. Role of the INK4a locus in tumor suppression and cell
mortality. Cell 85, 27–37 (1996).
32. Cheong, C. et al. Role of INK4a locus in normal eye development and cataract
genesis. Mech. Ageing Dev. 127, 633–638 (2006).
33. Hohman, T. C. Hereditary Retinal Dystrophy. Handb. Exp. Pharmacol. 242,
337–367 (2016).
34. Miura, K. et al. ARAP1: a point of convergence for Arf and Rho signaling.
Mol. Cell 9, 109–119 (2002).
35. Campa, F. et al. A PH domain in the Arf GTPase-activating protein (GAP)
ARAP1 binds phosphatidylinositol 3,4,5-trisphosphate and regulates Arf GAP
activity independently of recruitment to the plasma membranes. J. Biol. Chem.
284, 28069–28083 (2009).
36. Yoon, H. Y., Lee, J. S. & Randazzo, P. A. ARAP1 regulates endocytosis of
EGFR. Trafﬁc 9, 2236–2252 (2008).
37. Moshiri, A. et al. Arap1 deﬁciency causes photoreceptor degeneration in mice.
Invest. Ophthalmol. Vis. Sci. 58, 1709–1718 (2017).
COMMUNICATIONS BIOLOGY | DOI: 10.1038/s42003-018-0226-0 ARTICLE
COMMUNICATIONS BIOLOGY |           (2018) 1:236 | DOI: 10.1038/s42003-018-0226-0 | www.nature.com/commsbio 9
38. Dinamarca, M. C. et al. Ring ﬁnger protein 10 is a novel synaptonuclear
messenger encoding activation of NMDA receptors in hippocampus. Elife 5,
e12430 (2016).
39. Hoshikawa, S., Ogata, T., Fujiwara, S., Nakamura, K. & Tanaka, S. A novel
function of RING ﬁnger protein 10 in transcriptional regulation of the myelin-
associated glycoprotein gene and myelin formation in Schwann cells. PLoS
ONE 3, e3464 (2008).
40. Charette, J. R. et al. A chemical mutagenesis screen identiﬁes mouse models
with ERG defects. Adv. Exp. Med. Biol. 854, 177–183 (2016).
41. Greenwald, S. H. et al. Mouse models of NMNAT1-leber congenital amaurosis
(LCA9) recapitulate key features of the human disease. Am. J. Pathol. 186,
1925–1938 (2016).
42. Adachi, M. et al. Similar and distinct properties of MUPP1 and Patj, two
homologous PDZ domain-containing tight-junction proteins. Mol. Cell. Biol.
29, 2372–2389 (2009).
43. Feldner, A. et al. Loss of Mpdz impairs ependymal cell integrity leading to
perinatal-onset hydrocephalus in mice. EMBO Mol. Med. 9, 890–905 (2017).
44. van Rossum, A. G. et al. Pals1/Mpp5 is required for correct localization of
Crb1 at the subapical region in polarized Muller glia cells. Hum. Mol. Genet.
15, 2659–2672 (2006).
45. van de Pavert, S. A. et al. Crb1 is a determinant of retinal apical Müller glia cell
features. Glia 55, 1486–1497 (2007).
46. Al-Dosari, M. S. et al. Mutation in MPDZ causes severe congenital
hydrocephalus. J. Med. Genet. 50, 54–58 (2013).
47. Saugier-Veber, P. et al. Hydrocephalus due to multiple ependymal
malformations is caused by mutations in the MPDZ gene. Acta Neuropathol.
Commun. 5, 36 (2017).
48. Shaheen, R. et al. The genetic landscape of familial congenital hydrocephalus.
Ann. Neurol. 81, 890–897 (2017).
49. Periyasamy, P. et al. Age-related cataracts: Role of unfolded protein response,
Ca2+mobilization, epigenetic DNA modiﬁcation, and loss of Nrf2/Keap1
dependent cytoprotection. Prog. Retin. Eye Res. 60, 1–19 (2017).
50. Datta, S. et al. The impact of oxidative stress and inﬂammation on RPE
degeneration in non-neovascular AMD. Prog. Retin. Eye Res. 60, 201–218 (2017).
51. Koscielny, G. et al. The International Mouse Phenotyping Consortium Web
Portal, a uniﬁed point of access for knockout mice and related phenotyping
data. Nucl. Acids Res. 42, 802–809 (2014).
52. Krebs, M. P. et al. Mouse models of human ocular disease for translational
research. PLoS ONE 12, e0183837 (2017).
53. Mattapallil, M. J. et al. The Rd8 mutation of the Crb1 gene is present in vendor
lines of C57BL/6N mice and embryonic stem cells, and confounds ocular
induced mutant phenotypes. Invest. Ophthalmol. Vis. Sci. 53, 2921–2927 (2012).
54. Low, B. E. et al. Correction of the Crb1rd8 allele and retinal phenotype in
C57BL/6N mice via TALEN-mediated homology-directed repair. Invest.
Ophthalmol. Vis. Sci. 55, 387–395 (2014).
55. Mehalow, A. K. et al. CRB1 is essential for external limiting membrane
integrity and photoreceptor morphogenesis in the mammalian retina. Hum.
Mol. Genet. 12, 2179–2189 (2003).
56. Aleman, T. S. et al. Human CRB1-associated retinal degeneration: comparison
with the rd8 Crb1-mutant mouse model. Invest. Ophthalmol. Vis. Sci. 52,
6898–6910 (2011).
57. Moore, B. A. et al. A population study of common ocular abnormalities in
C57BL/6N Rd8 Mice. Invest. Ophthalmol. Vis. Sci. 59, 2252–2261 (2018).
58. Varshney, N. et al. A review of Von Hippel-Lindau Syndrome. J. Kidney
Cancer Vhl. 4, 20–29 (2017).
59. Parisi, M. & Glass, I. Joubert Syndrome (GeneReviews, University of
Washington, Seattle, 2017).
60. Weihbrecht, K., et al. Keeping an eye on Bardet-Biedl Syndrome: A
comprehensive review of the role of Bardet-Biedl Syndrome genes in the eye.
Med. Res. Arch. 5, https://doi.org/10.18103/mra.v5i9.1526.
61. Fritsche, L. G. et al. Age-related macular degeneration: genetics and biology
coming together. Annu. Rev. Genom. Hum. Genet. 15, 151–171 (2014).
62. Black, J. R. & Clark, S. J. Age-related macular degeneration: genome-wide
association studies to translation. Genet. Med. 18, 283–289 (2016).
63. Cooke Bailey, J. N., Pericak-Vance, M. A. & Haines, J. L. Genome-wide
association studies: getting to pathogenesis, the role of inﬂammation/
complementin age-related macular degeneration. Cold Spring Harb. Perspect.
Med. 4, a017186 (2014).
64. Scheetz, T. E. et al. A genome-wide association study for primary open angle
glaucoma and macular degeneration reveals novel Loci. PLoS ONE 8, e58657
(2013).
65. Shefﬁeld, V. C. & Stone, E. M. Genomics and the eye. N. Engl. J. Med. 364,
1932–1942 (2011).
66. van Huet, R. A. et al. The efﬁcacy of microarray screening for autosomal recessive
retinitis pigmentosa in routine clinical practice. Mol. Vis. 21, 461–476 (2015).
67. Glöckle, N. et al. Panel-based next generation sequencing as a reliable and
efﬁcient technique to detect mutations in unselected patients with retinal
dystrophies. Eur. J. Hum. Genet. 22, 99–104 (2014).
68. Neveling, K. et al. Next-generation genetic testing for retinitis pigmentosa.
Hum. Mutat. 33, 963–972 (2012).
69. Searle, A. G., Edwards, J. H. & Hall, J. G. Mouse homologues of human
hereditary disease. J. Med. Genet. 31, 1–19 (1994).
70. Gillespie, R. L. et al. Personalized diagnosis and management of congenital
cataract by next-generation sequencing. Ophthalmol 121, 2124–2137 (2014).
71. Karp, N. A. et al. Applying the ARRIVE guidelines to an in vivo database.
PLoS Biol. 13, e1002151 (2015).
72. Kurbatova, N., Mason, J. C., Morgan, H., Meehan, T. F. & Karp, N. A.
PhenStat: A tool kit for standardized analysis of high throughput phenotypic
data. PLoS ONE 10, e0131274 (2015).
73. Wolf, J. C. & Maack, G. Evaluating the credibility of histopathology data in
environmental endocrine toxicity studies. Environ. Toxicol. Chem. 36,
601–611 (2017).
74. Ward, J. M., Schoﬁeld, P. N. & Sundberg, J. P. Reproducibility of
histopathological ﬁndings in experimental pathology of the mouse: a sorry tail.
Lab. Anim. 46, 146–151 (2017).
75. Krebs, M. P., Xiao, M., Sheppard, K., Hicks, W. & Nishina, P. M. Bright-ﬁeld
imaging and optical coherence tomography of the mouse posterior eye.
Methods Mol. Biol. 1438, 395–415 (2016).
76. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc.
4, 44–57 (2009).
77. Supek, F., Bošnjak, M., Škunca, N. & Šmuc, T. Revigo summarizes and
visualizes long lists of gene ontology terms. PLoS ONE 6, e21800 (2011).
78. Stark, C. et al. BioGRID: a general repository for interaction datasets. Nucl.
Acids Res. 34, D535–D539 (2006).
79. Patil, A., Nakai, K. & Nakamura, H. HitPredict: A database of quality assessed
protein-protein interactions in nine species. Nucl. Acids Res. 39, D744–D749
(2011).
80. Orchard, S. et al. The MIntAct project - IntAct as a common curation
platform for 11 molecular interaction databases. Nucl. Acids Res. 42,
D358–D363 (2014).
81. Chatr-aryamontri, A. et al. MINT: the Molecular INTeraction database. Nucl.
Acids Res. 35, D572–D574 (2007).
82. von Mering, C. et al. STRING: A database of predicted functional associations
between proteins. Nucl. Acids Res. 31, 258–261 (2003).
83. Cline, M. S. et al. Integration of biological networks and gene expression data
using Cytoscape. Nat. Protoc. 2, 2366–2382 (2007).
Acknowledgements
We thank all the various funding agencies supporting the International Mouse Pheno-
typing Consortium. Research reported in this publication was supported by the NIH
Common Fund, the Ofﬁce Of The Director, and the National Human Genomic Research
Institute of the National Institutes of Health under Award Number U42OD011185 (S.A.
M.), U54HG006332 (R.E.B. and K.L.S.), UM1OD023222 (to R.E.B., S.A.M., and J.K.W.),
K08EY027463 (A.M.), EY027860 (P.M.N.), U42OD012210 (K.C.K.L.), U54HG006364,
U42OD011175, and UM1OD023321 (K.C.K.L. and C.M.), UM1HG006370 (J.M., T.F.M.,
H.P., and P.F.), U54HG006348 and Medical Research Council Strategic Award 53650 (S.
G., S.W.), K08EY021142 (S.M.T.), P30EY12576 (NEI visual sciences microscopy core
grant to UC Davis), 5P30CA034196 (NIH cancer center support core grant to JAX),
2013M3A9D5072550, 2012M3A9B6055344, 2012M3A9D1054622, 2013M3A9B6046417
(NRF to J.K.S), and Wellcome Trust grant (WT098051). We gratefully acknowledge
additional funding sources, including the Research for Preventing Blindness and Inter-
national Retina Research Foundation (A.M.), and Government of Canada through
Genome Canada and Ontario Genomics (OGI-051) (C.M, S.D.M.B.). Paul Fitzgerald
(UC Davis) assisted in the interpretation of lens ﬁndings. Outstanding technical support
was provided by Monica Motta, Brad Shibata, Devin Humpal, Addy Tham, Karrie
Beeman, Heather Tolentino, Todd Tolentino, Esi Djan, Milton Pham, and Amanda
Trainor at UC Davis, Chaouki Bam’Hamed, Raphaël Bour, Alain Guimond, Valérie
Lalanne, and Aline Lux at PHENOMIN-ICS, and Samantha Burrill and Jennifer Ryan for
ocular phenotyping at JAX. We also thank James Clark for data management and Wanda
Jordan for training phenotypers at JAX.
Author contributions
B.A.M. performed gene analysis, wrote the manuscript, and created the ﬁgures, and was
directly and indirectly involved in ocular phenotyping and data procurement. A.M.
performed gene analysis, wrote the manuscript, and created the ﬁgures. M.J.R., M.P.K.,
P.M.N., S.A.M., D.M.I., S.M.G., J.M., T.M. and B.C.L. created the ﬁgures and were
indirectly involved in ocular phenotying and data procurement. L.S., S.G.E., A.C., S.M.T.,
C.R., L.B., D.C., H.P., P.F., H.M., Y.H., C.M., A.M.F., L.M.J.N., Z.B., C.O., S.N., H.A., M.
E., C.-W.H., S.K., U.U., C.A., R.B., J.J.G., J.R.S., M.E.D., J.D.H., K.L.S., V.P., V.K., R.E.B.,
S.D.M.B., S.W., H.C., M.S., S.C.-M., R.J., X.G., A.-M.M., D.S., E.S., L.S., A.L.B., M.J.J.,
T.S., S.W., J.K.W., J.K.S., G.T.-V., M.M., C.F., N.K., R.R.-S., M.H.de.A., W.W., K.C.K.L.,
and C.J.M. were directly or indirectly involved in ocular phenotyping, data procurement,
and review and editing of the manuscript. Members of the International Mouse
ARTICLE COMMUNICATIONS BIOLOGY | DOI: 10.1038/s42003-018-0226-0
10 COMMUNICATIONS BIOLOGY |           (2018) 1:236 | DOI: 10.1038/s42003-018-0226-0 | www.nature.com/commsbio
Phenotyping Consortium (I.M.P.C.) Member list were all directly involved in ocular
phenotyping. All authors read and approved the ﬁnal manuscript.
Additional information
Supplementary information accompanies this paper at https://doi.org/10.1038/s42003-
018-0226-0.
Competing interests: The authors declare no competing interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
This is a U.S. government work and not under copyright protection in the U.S.; foreign
copyright protection may apply 2018
Bret A. Moore1, Brian C. Leonard2, Lionel Sebbag1, Sydney G. Edwards1, Ann Cooper1, Denise M. Imai3,
Ewan Straiton 4, Luis Santos4, Christopher Reilly3, Stephen M. Griffey3, Lynette Bower5, David Clary5,
Jeremy Mason 6, Michel J. Roux 7,8,9,10,11, Hamid Meziane7,8,9,10,11,
Yann Herault 7,8,9,10,11, International Mouse Phenotyping Consortium†, Colin McKerlie 12,13,
Ann M. Flenniken12,14, Lauryl M.J. Nutter12,13, Zorana Berberovic12,14, Celeste Owen12,14, Susan Newbigging12,14,
Hibret Adissu12,14, Mohammed Eskandarian12,14, Chih-Wei Hsu15, Sowmya Kalaga15, Uchechukwu Udensi15,
Chinwe Asomugha15, Ritu Bohat16, Juan J. Gallegos16, John R. Seavitt16, Jason D. Heaney16, Arthur L. Beaudet16,
Mary E. Dickinson15,16, Monica J. Justice12,13,16, Vivek Philip17, Vivek Kumar 17, Karen L. Svenson17,
Robert E. Braun17, Sara Wells4, Heather Cater4, Michelle Stewart4, Sharon Clementson-Mobbs4,
Russell Joynson4, Xiang Gao18, Tomohiro Suzuki19, Shigeharu Wakana 19, Damian Smedley20, J. K Seong21,
Glauco Tocchini-Valentini22, Mark Moore23, Colin Fletcher24, Natasha Karp25, Ramiro Ramirez-Solis25,
Jacqueline K. White17,25, Martin Hrabe de Angelis 26, Wolfgang Wurst26, Sara M. Thomasy2,27, Paul Flicek 6,
Helen Parkinson6, Steve D.M. Brown4, Terrence F. Meehan6, Patsy M. Nishina17, Stephen A. Murray17,
Mark P. Krebs17, Ann-Marie Mallon4, K.C.Kent Lloyd 5, Christopher J. Murphy2,27 & Ala Moshiri27
1William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis 95616 CA, USA.
2Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA.
3Comparative Pathology Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA. 4Medical Research
Council Harwell Institute (Mammalian Genetis Unit and Mary Lyon Center, Harwell, Oxfordshire OX11 0RD, UK. 5Mouse Biology Program, and
Department of Surgery, School of Medicine, University of California-Davis, Davis, CA 95618, USA. 6European Molecular Biology Laboratory,
European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1 SD, UK. 7Institut de Génétique et de Biologie
Moléculaire et Cellulaire, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch, France. 8Centre National de la Recherche Scientiﬁque,
UMR7104 Illkirch, France. 9Institut National de la Santé et de la Recherche Médicale, U1258 Illkirch, France. 10Université de Strasbourg, 1 rue
Laurent Fries, 67404 Illkirch, France. 11CELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, 1 rue
Laurent Fries, 67404 Illkirch-Graffenstaden, France. 12The Centre for Phenogenomics, Toronto, ON M5T 3H7, Canada. 13The Hospital for Sick
Children, Toronto, ON M5G 1X8, Canada. 14Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
15Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. 16Department of Molecular and
Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. 17The Jackson Laboratory, Bar Harbor, ME 04609, USA. 18SKL of
Pharmaceutical Biotechnology and Model Animal Research Center, Collaborative Innovation Center for Genetics and Development, Nanjing
Biomedical Research Institute, Nanjing University, Nanjing 210061, China. 19RIKEN BioResource Center, Tsukuba, Ibaraki 305-0074, Japan.
20Clinical Pharmacology, Charterhouse Square, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London
EC1M 6BQ, UK. 21Korea Mouse Phenotyping Consortium (KMPC) and BK21 Program for Veterinary Science, Research Institute for Veterinary
Science, College of Veterinary Medicine, Seoul National University, 599 Gwanangno, Gwanak-gu, Seoul 08826, South Korea. 22Monterotondo
Mouse Clinic, Italian National Research Council (CNR), Institute of Cell Biology and Neurobiology, Adriano Buzzati-Traverso Campus, Via Ramarini,
I-00015 Monterotondo Scalo, Italy. 23International Mouse Phenotyping Consortium, San Anselmo, CA 94960, USA. 24National Institutes of Health,
Bethesda, MD 20205, USA. 25The Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK. 26German
Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter
Landstraße 1, 85764 Neuherberg, Germany. 27Department of Ophthalmology & Vision Science, School of Medicine, U.C. Davis, Sacramento, CA
95817, USA. These authors contributed equally: Brian C. Leonard, Lionel Sebbag. †A full list of consortium members appears at the end of the paper.
COMMUNICATIONS BIOLOGY | DOI: 10.1038/s42003-018-0226-0 ARTICLE
COMMUNICATIONS BIOLOGY |           (2018) 1:236 | DOI: 10.1038/s42003-018-0226-0 | www.nature.com/commsbio 11
International Mouse Phenotyping Consortium
Anna Swan4, Ruairidh King4, Piia Keskivali-Bond4, Lois Kelsey12, Igor Vukobradovic12, Dawei Qu12, Ruolin Guo12,
Elisa Tran12, Lily Morikawa12, Milan Ganguly12, Napoleon Law12, Xueyuan Shang12, Patricia Feugas12,
Yanchun Wang12, Yingchun Zhu12, Kyle Dufﬁn12, Ayexa Ramirez12, Patricia Penton12, Valerie Laurin12,
Shannon Clarke12, Qing Lan12, Gillian Sleep12, Amie Creighton12, Elsa Jacob12, Ozge Danisment12, Joanna Joeng12,
Marina Gertsenstein12, Monica Pereira12, Sue MacMaster12, Sandra Tondat12, Tracy Carroll12, Jorge Cabezas12,
Amit Patel12, Jane Hunter12, Gregory Clark12, Mohammed Bubshait12, David Miller12, Khondoker Sohel12,
Alexandr Bezginov12, Matthew McKay16, Kevin Peterson16, Leslie Goodwin16, Rachel Urban16, Susan Kales16,
Rob Hallett16, Dong Nguyen-Bresinsky16, Timothy Leach16, Audrie Seluke16, Sara Perkins16, Amanda Slater16,
Rick Bedigian16, Leah Rae Donahue16, Robert Taft16, James Denegre16, Zachery Seavey16, Amelia Willett16,
Lindsay Bates16, Leslie Haynes16, Julie Creed16, Catherine Witmeyer16, Willson Roper16, James Clark16,
Pamela Stanley16, Samantha Burrill16, Jennifer Ryan16, Yuichi Obata19, Masaru Tamura19, Hideki Kaneda19,
Tamio Furuse19, Kimio Kobayashi19, Ikuo Miura19, Ikuko Yamada19, Hiroshi Masuya19, Nobuhiko Tanaka19,
Shinya Ayabe19, Atsushi Yoshiki19, Valerie Vancollie25, Francesco Chiani28, Chiara Di Pietro28,
Gianfranco Di Segni28, Olga Ermakova28, Filomena Ferrara28, Paolo Fruscoloni28, Alessia Gambadoro28,
Serena Gastaldi28, Elisabetta Golini28, Gina La Sala28, Silvia Mandillo28, Daniela Marazziti28, Marzia Massimi28,
Rafaele Matteoni28, Tiziana Orsini28, Miriam Pasquini28, Marcello Raspa28, Aline Rauch28, Gianfranco Rossi28,
Nicoletta Rossi28, Sabrina Putti28, Ferdinando Scavizzi28 & Giuseppe D. Tocchini-Valentini28
28Monterotondo Mouse Clinic, Italian National Research Council (CNR), Institute of Cell Biology and Neurobiology, Adriano Buzzati-Traverso
Campus, Via Ramarini, I-00015 Monterotondo Scalo, Italy
ARTICLE COMMUNICATIONS BIOLOGY | DOI: 10.1038/s42003-018-0226-0
12 COMMUNICATIONS BIOLOGY |           (2018) 1:236 | DOI: 10.1038/s42003-018-0226-0 | www.nature.com/commsbio
